Recent Articles from Business Wire

Nextpower (Nasdaq: NXT, formerly Nextracker) and Abunayyan Holding today announced the completion of the incorporation of the previously announced joint venture, Nextpower Arabia, headquartered in Riyadh, Kingdom of Saudi Arabia. The new joint venture will accelerate the deployment of utility-scale solar power plants across the Middle East and North Africa (MENA) region, supporting national and regional renewable energy transformation objectives and Net Zero targets.

Belden Inc. (NYSE: BDC), a leading global supplier of specialty networking solutions, today announced that, subject to market conditions, it intends to offer €450 million in aggregate principal amount of senior subordinated notes due 2033 (the “Notes”) for sale to eligible purchasers in a private offering (the “Notes Offering”).

Kosmos Energy Ltd. (“Kosmos” or the “Company,”) (NYSE/LSE: KOS) announced today that its wholly-owned subsidiary, Kosmos Energy GTA Holdings (the “Issuer”), intends to offer, subject to market conditions and other factors, $350 million aggregate principal amount of senior secured bonds in the Nordic bond market. The senior bonds will be due in 2031 and will be fully and unconditionally guaranteed by the Company, as well as the Company’s wholly-owned subsidiaries, Kosmos Energy Tortue Finance, Kosmos Energy Senegal, Kosmos Energy Investments Senegal Limited and Kosmos Energy Mauritania. The senior bonds will also be guaranteed on an unsecured basis by certain of the Company’s subsidiaries that also guarantee the Company’s existing senior unsecured notes.

Avolon, a leading global aviation finance company, issues an update for the fourth quarter (‘Q4’) and 2025 full year (‘FY’).

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced its 2026 priorities across its five growth pillars focused on advancing product commercialization, regulatory milestones and automation system innovations to support its goal for $2 billion of combined annual pillar sales in 2028.

Saba Capital Management, L.P. (together with certain of its affiliates, “Saba” or “we”), the largest shareholder of Edinburgh Worldwide Investment Trust PLC (EWI:LSE) (“EWI” or the “Company”), today issued the following statement in response to recent attempts by the Company and its Board of Directors (the “Board”) to mislead shareholders about Saba’s campaign. In addition, Saba also outlined its concerns regarding the inaccuracies of EWI’s claims and demonstrated key facts that reinforce the urgent need for shareholder-driven change.

Oxford Nanopore Technologies today announces that the GridION™ Dx is now both CE and UKCA marked, making it the company’s first IVD device registered in the UK and Europe. The CE and UKCA certification confirms that GridION™ Dx meets stringent international standards for quality, safety, and performance, positioning Oxford Nanopore for future adoption in regulated clinical markets and reflecting its long-term commitment to sequencing-based diagnostics.

Kubota dealerships were ranked highest in the 2026 Pied Piper PSI® Internet Lead Effectiveness® (ILE®) Compact Tractor Industry Study, which measured dealership responsiveness to internet sales leads. Pied Piper submitted customer inquiries through 772 compact tractor dealership websites representing all major brands. Kubota dealerships achieved an average ILE score of 37 out of 100, while the total industry averaged 29, however both dropped five and four points respectively since the previous year’s study. Following Kubota in the rankings were TYM, Mahindra, John Deere, and Yanmar.

Coastal Bend LNG today announced it has selected KBR, Inc. (NYSE: KBR) and Técnicas Reunidas (IBEXC: TRE) for the front-end engineering and design (FEED) of their planned natural gas liquefaction and export facility along the Texas Gulf Coast. Upon positive final investment decision, KBR and Técnicas Reunidas will proceed to execute the engineering, procurement, and construction (EPC) phase of the project.

Mattel, Inc. (NASDAQ: MAT) unveiled today its first-ever autistic Barbie doll created with guidance from the autistic community to represent common ways autistic people may experience, process, and communicate about the world around them. This doll invites more children to see themselves represented in Barbie.

At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹ΨTP).

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today released preliminary unaudited results for the fourth quarter and full year ended December 31, 2025. The Company expects the following:

The latest research from Omdia reveals that total shipments of desktops, notebooks and workstations in Q4 2025 grew 10.1% to 75 million units. This brought full-year 2025 PC shipments to 279.5 million units, a 9.2% increase over 2024 volumes. Notebook (including mobile workstation) shipments reached 58.6 million units in Q4 and 220.4 million units in the full year, achieving 8% growth in 2025. Desktop (including desktop workstation) shipments in Q4 landed at 16.2 million units, bringing the total 2025 volume to 59 million units, a 14.4% increase over the previous year.

FPT Software, the global IT services subsidiary of FPT Corporation (FPT), is positioned as a Leader in the IDC MarketScape: Asia/Pacific AI-Enabled Front Office Conversational AI Software 2025 Vendor Assessment (doc # AP52998625e, November 2025).

Ant International, a leading global payment, digitisation, and financial technology provider, is collaborating on the launch of Google’s Universal Commerce Protocol (UCP), a new open standard for agentic commerce that works across the entire shopping journey — from discovery and buying to post-purchase support.

CDB Aviation, a wholly owned Irish subsidiary of China Development Bank Financial Leasing Co., Ltd. (“CDB Leasing”), announced today that CDB Aviation Hong Kong (Limited), a Hong Kong incorporated entity wholly owned by CDB Aviation, executed a new Sustainability Linked Loan (“SLL”) transaction on December 19, 2025, anchored with a five-year $710 million unsecured term loan facility.

UPPF announced the grand opening of its Technical Center in Shanghai, a 3,000 sq ft facility designed to deliver faster, more comprehensive product support, strengthen quality management, and expand installation training for dealers and partners across Asia and beyond. The new center aligns with UPPF’s commitment to practical innovation and customer success, captured in the event theme: “Your Growth, Our Mission.”

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Sun Country Airlines Holdings, Inc. (NASDAQ: SNCY) to Allegiant Travel Company for 0.1557 shares of Allegiant common stock and $4.10 in cash for each Sun Country share is fair to Sun Country shareholders.

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Allegiant Travel Company (NASDAQ: ALGT) and Sun Country Airlines is fair to Allegiant shareholders. Upon completion of the proposed transaction, Allegiant shareholders will own approximately 67% of the combined company.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a record Total Contract Value (TCV) of >$1.1 billion as of December 31, 2025. During 2025, Tempus signed data agreements with over 70 customers, spanning both large and mid-sized pharma, including AstraZeneca, GlaxoSmithKline, Bristol Myers Squibb, Pfizer, Novartis, Merck, Abbvie, Daiichi Sankyo, Eli Lilly, Boehringer Ingelheim, and biotechs including Incyte, Servier, Aspera Biomedicines, and Whitehawk Therapeutics, as an increasing number of biopharma companies are incorporating Tempus’ unique, multimodal dataset into their drug discovery and development efforts.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced select, preliminary, unaudited results for the fourth quarter and full year ended December 31, 2025.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced business and program updates ahead of upcoming investor meetings in January, including the company’s scheduled webcast from the 44th annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 5:15 p.m. ET/2:15 p.m. PT.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced preliminary, unaudited results for the quarter and full year ended December 31, 2025.

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced its new five-year strategy, “Alnylam 2030,” focused on scaling the Company’s operations through achieving leadership in ATTR amyloidosis, driving long-term growth through sustainable innovation, and delivering exceptional financial results with discipline and agility. Alnylam also today reported preliminary* fourth quarter and full year 2025 global net product revenues for AMVUTTRA, ONPATTRO, GIVLAARI and OXLUMO.

Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced preliminary, unaudited financial results for the fourth quarter and full year ended December 31, 2025.

Aristocrat Leisure Limited (ASX:ALL) and Light & Wonder (ASX:LNW) have agreed to settle their pending litigation in Australia and the United States which Aristocrat brought following the launch of Light & Wonder’s Dragon Train game, which Aristocrat contends was developed using Aristocrat’s trade secrets and copyright works. Aristocrat later made similar claims against Light & Wonder’s Jewel of the Dragon game.

Exelixis, Inc. (Nasdaq: EXEL) today announced its preliminary unaudited financial results for the fiscal year 2025, provided financial guidance for fiscal year 2026 and delivered an update on its business. Exelixis anticipates 2026 will be a significant year of clinical, regulatory and commercial progress as the company grows its current cabozantinib business, works toward building a potential second commercial franchise with zanzalintinib and moves its earlier stage pipeline forward. As outlined at its December 2025 R&D Day, the company seeks to leverage its diverse pipeline and key clinical collaborations to build next-generation oncology franchises that can improve standards of care for patients with cancer.

Cerus Corporation (Nasdaq: CERS) today announced preliminary product revenue for the fourth quarter and full-year 2025, as well as provided 2026 product revenue guidance and select milestones for 2026.

As point-of-sale platforms increasingly expand to support restaurants, services, and multiple verticals, many retailers are finding that generalized systems fail to meet the specific demands of in-store retail operations. In response to this shift, Vibe Retail POS is gaining recognition for a different approach—building point-of-sale technology exclusively for retail.

As we enter 2026, in-store shopping continues to evolve, embracing a more experiential approach. Trends like shoppertainment, phygital integrations, AI-driven customization and frictionless payments are emerging as consumers demand a more immersive, brand-led experience.

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development with Biogen (Nasdaq: BIIB) as a first-in-class potential disease-modifying treatment for Dravet syndrome. Today, the Company announced accelerated timelines for the completion of enrollment and a Phase 3 data readout from the EMPEROR study. Completion of enrollment of 150 patients is now expected in the second quarter of 2026. This enrollment progress puts the Phase 3 EMPEROR study on track for a data readout in mid-2027 that is anticipated to support the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA). The Company plans to initiate a rolling NDA submission in the first half of 2027.

Genialis, the RNA biomarker company, today announced that Swiss-based biopharmaceutical company Debiopharm has deployed the Genialis™ Expressions software platform within its cloud infrastructure to support biomarker discovery and multiomics data analytics. The agreement extends the companies’ multi-year collaboration and provides Debiopharm access to Genialis’ integrated technology stack for raw data processing and AI-driven biomarker modeling.

Torq, the established Agentic AI security operations pioneer, today announced it has closed a massive $140 million Series D funding round, propelling its valuation to $1.2 billion and total funding to $332M.

Impinj, Inc. (NASDAQ: PI), a leading RAIN RFID provider and Internet of Things pioneer, today announced a licensing agreement with EM Microelectronic, a semiconductor manufacturer specialized in the design and production of ultra-low power, low voltage integrated circuits (IC), to integrate Impinj Gen2X into future EM endpoint ICs.

Sensormatic Solutions, the leading global retail solutions portfolio of Johnson Controls (NYSE: JCI), is offering retailers a new way to implement a data-driven approach to LP and organized retail crime (ORC) prevention using trusted acousto-magnetic (AM) technologies. Its Category-Level Shrink Insights ecosystem is designed to turn existing electronic article surveillance (EAS) infrastructure into an intelligent LP solution, driving operational improvements and customer experience excellence. Visitors of the 2026 NRF Big Show can see the new intelligence solution—brought to life in the Sensormatic Solutions Shrink Analyzer application to provide insights into retailers’ top theft categories—in action at Sensormatic Solutions booth (#5321), Jan. 11-13.

Xerox and Lexmark today unveil a unified suite of retail solutions at NRF 2026: Retail’s Big Show, marking their first joint industry appearance. The newly combined company’s offering signals a new era in retail technology and introduces innovations designed to help brands “See It, Show It, Support It, Scale It.”

Sensormatic Solutions, the leading global retail solutions portfolio of Johnson Controls (NYSE: JCI), has added a new, highly customizable and retail-media-ready electronic article surveillance (EAS) system to its portfolio. The Sensormatic Solutions Flexible Loss-prevention & Engagement Experience (FLEX) platform is designed to enhance front-of-store real estate by combining visual merchandising, digital content management tools, and a full suite of loss prevention (LP) technology. FLEX blends seamlessly into the store design, while helping deliver a gateway for the shopper experience. Those in attendance at the 2026 NRF Big Show will have the opportunity to see the solution in person at booth (#5321), Jan. 11-13.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Beta Bionics, Inc. (“Beta Bionics” or “the Company”) (NASDAQ: BBNX) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ardent Health, Inc. (“Ardent” or “the Company”) (NYSE: ARDT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Kinaset Therapeutics, a clinical-stage biopharmaceutical company developing a novel and differentiated inhaled therapeutic candidate to treat serious respiratory diseases, today announced the closing of a $103 million Series B financing. New investors RA Capital Management and Forge Life Science Partners led the financing, with participation from new investors EQT Life Sciences, Vivo Capital, Schroders Capital, Willett Advisors, Pictet Alternative Advisors, Sixty Degree Capital and existing investors, Atlas Venture, 5AM Ventures and Gimv.

Pfizer Inc. (NYSE: PFE) today announced positive results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and FOLFIRI (fluorouracil, leucovorin, and irinotecan) in patients with previously untreated metastatic colorectal cancer (mCRC) with a BRAF V600E mutation. At the time of this analysis, the BRAFTOVI combination regimen with FOLFIRI and cetuximab demonstrated a clinically meaningful and statistically significant improvement in confirmed objective response rate (ORR) assessed by blinded independent central review (BICR) compared to patients receiving standard-of-care treatment FOLFIRI with or without bevacizumab (64.4% vs 39.2%, odds ratio =2.76, p=0.001). These data will be presented today in an oral presentation (Abstract 13) at the 2026 American Society of Clinical Oncology Gastrointestinal (ASCO GI®) Cancers Symposium and highlighted in the ASCO GI official press program.

Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until January 12, 2026 to file lead plaintiff applications in a securities class action lawsuit against Stride, Inc. (“Stride” or the “Company”) (NYSE: LRN), if they purchased or otherwise acquired the Company’s securities between October 22, 2024 and October 28, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of Virginia.

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Varonis Systems, Inc. (NASDAQ: VRNS) common stock between February 4, 2025 and October 28, 2025, both dates inclusive (the “Class Period”), have until March 9, 2026 to seek appointment as lead plaintiff of the Varonis class action lawsuit. Captioned Molchanov v. Varonis Systems, Inc., No. 26-cv-00117 (S.D.N.Y.), the Varonis class action lawsuit charges Varonis and certain of Varonis’ top executives with violations of the Securities Exchange Act of 1934.

Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until March 9, 2026 to file lead plaintiff applications in a securities class action lawsuit against Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT), if they purchased or otherwise acquired the Company’s securities between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Middle District of Tennessee.

Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of up to 214,331 shares of common stock. Awards were made to seventeen new employees of the Company. The awards were granted as an inducement material to the new employees becoming employees of the Company in accordance with Nasdaq Listing Rule 5635(c)(4) and have been approved by the Company’s Compensation Committee. The inducement awards were granted on January 6, 2026. The options have a ten (10) year term and an exercise price of $18.66 per share, the closing price per share of the Company’s common stock as reported by Nasdaq on January 6, 2026. The options were granted from a pool of equity incentives reserved by the Compensation Committee on January 22, 2025 for issuance as inducements to new employees in accordance with Nasdaq Listing Rule 5635(c)(4).

Metropolitan Water District General Manager Shivaji Deshmukh issues the following statement regarding the U.S. Bureau of Reclamation’s release today of a Draft Environmental Impact Statement for post-2026 operations of Lake Powell and Lake Mead.

MindWalk Holdings Corp. (NASDAQ:HYFT) (“MindWalk” or the “Company”), a Bio-Native AI therapeutic research and technology company, today announced an advance in its universal influenza program following the identification of a breakthrough functional constraint that persists across influenza viruses despite continual evolution.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Varonis Systems, Inc. (“Varonis” or “the Company”) (NASDAQ: VRNS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The law firm of Kirby McInerney LLP reminds Freeport-McMoran Inc. (“Freeport” or the “Company”) (NYSE:FCX) investors of the January 12, 2026 deadline to seek lead plaintiff appointment in the class action filed on behalf of investors who acquired Freeport securities between February 15, 2022 through September 24, 2025 (“the Class Period”).

KBRA releases the December 2025 issue of CMBS Trend Watch.

Peak Technology, a leading provider of quick turn prototyping and advanced manufacturing services for the Semiconductor, Bio-Medical, Aerospace, and other Deep Tech industries, is proud to announce the launch of APEX, its proprietary Advanced Purchase Order Execution System. This new platform formalizes Peak’s unique manufacturing technology by providing true OEM-to-OEM Collaboration capability and delivering unmatched responsiveness, integration, and supply chain intelligence to meet the demands of next-generation manufacturing.

For the fourth time, Strong Tower Consulting has been honored by Seattle Business Magazine as one of Washington’s Best Places to Work, reaffirming the firm’s enduring commitment to its people and inclusive culture, while leading the industry forward with an evolution towards enterprise-grade, governed AI.

Four Corners Property Trust (NYSE:FCPT), a real estate investment trust primarily engaged in the ownership and acquisition of high-quality, net-leased restaurant and retail properties (“FCPT” or the “Company”), is pleased to announce the acquisition of a GreatWater 360 Auto Care property for $1.2 million via sale-leaseback. GreatWater is a Michigan-based operator of approximately 150 full-service automotive centers in the Midwest and Texas. The property is located in a highly trafficked corridor in Indiana and is corporate-operated under a long term, triple net lease. The transaction was priced at a cap rate in range with previous FCPT transactions.

Edwards Lifesciences (NYSE: EW) today announced that the U.S. District Court for the District of Columbia has granted the motion from the U.S. Federal Trade Commission (FTC) for an injunction blocking the company’s proposed acquisition of JenaValve Technology. As a result, Edwards will not acquire JenaValve.

ReDiscover Television, a 100GROUP client, and CLO Prods proudly announce the world premiere of BirdDog, a gripping new indie drama-thriller series created and written by Christine Lozano. Filmed entirely in the vibrant border city of El Paso, Texas, BirdDog stars Jessica Jimenez, Nichole Hamilton, Talia Leilani, Adam Zarowski, Russell Elleby and Xavier Felix as a ragtag crew of FBI rejects recruited into BirdDog Unit under CISA, Cybersecurity and Infrastructure Security Agency. Evading midnight abductions and forced neural implants, the BirdDogs must expose and dismantle this rogue government agency harvesting citizens’ DNA, creating flawless replicants, and quietly exterminating anyone still fully human.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE:ARDT) securities during the period of July 18, 2024 through November 12, 2025, inclusive (“the Class Period”).

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Fermi Inc. (“Fermi” or “the Company”) (NASDAQ: FRMI) for violations of the federal securities laws.

Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Skye Bioscience, Inc. (NASDAQ: SKYE) between November 4, 2024 and October 3, 2025. Skye is a clinical stage biopharmaceutical company.

The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Firefly Aerospace Inc. (“Firefly”) (NASDAQ: FLY) on behalf of those who purchased or otherwise acquired Firefly: (1) common stock pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Offering Documents”) issued in connection with the company’s IPO conducted on or about August 7, 2025; and/or (2) securities between August 7, 2025 and September 29, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is January 12, 2026.

KBRA assigns an issuer rating of A-, a senior unsecured debt rating of A-, and a junior subordinated debt rating of BBB to MidCap Financial Issuer Trust, a wholly-owed subsidiary of MidCap FinCo Intermediate LLC ("the company" or "MidCap"), which serves as guarantor of the debt. MidCap is a commercial financial company that provides senior secured debt solutions to companies across multiple industries. The company is headquartered in Bethesda, MD. The ratings Outlook is Stable.

WD‑40 Company (NASDAQ: WDFC) today announced that Steve Brass, president and chief executive officer and Sara Hyzer, vice president, finance and chief financial officer will present at the 28th Annual ICR Conference in Orlando on Tuesday, January 13, 2026, at 10:00 a.m. Eastern Time.

USA Truck is proud to announce a significant and strategic transition to private, Arkansas-based ownership, marking a pivotal new chapter in the company’s more than 40-year history. Following the successful execution of an agreement for DSV to sell 100% of the shares in USA Truck, Inc. to UTAC, LLC, a private entity based in Arkansas, USA Truck officially returns to ownership rooted in the state where its legacy began. The transaction closed today.

BARK, Inc. (NYSE: BARK) (“BARK” or the “Company”), a leading global omnichannel dog brand with a mission to make all dogs happy, today announced that its Board of Directors (the "Board") has received a preliminary non-binding indicative proposal letter (the "Letter"), as noted in a Schedule 13D filing made January 9, 2026, from Great Dane Ventures, LLC (“Great Dane”), comprised of a group of the Company’s current stockholders, including Matt Meeker, the Company’s Chief Executive Officer and Executive Chairman of the Board, RRE Ventures, Resolute Ventures, Founders Circle Capital and Ironbound Partners Fund (collectively, the “Stockholder Group”). The Letter proposes that Great Dane would acquire all of the outstanding shares of the Company’s common stock not already beneficially owned by the Stockholder Group or their affiliates, in an all-cash transaction, for $0.90 per share (the “Proposal”).

The family of a 28-year-old man has filed a wrongful death lawsuit against Tesla yesterday after a Tesla (NASDAQ:TSLA) Model S operating on autopilot failed to detect his stopped motorcycle, striking him from behind, pinning him to the ground, and killing him.

VASTA PLATFORM LIMITED (NASDAQ: VSTA) ― “Vasta” or the “Company”, a leading, high-growth education company in Brazil, announced today that it has notified the Nasdaq Stock Market LLC (“Nasdaq”) of its decision to voluntarily delist its Class A Common Shares, par value U.S.$0.00005 per share (the “Shares”), from the Nasdaq Global Select Market.

The OpenAccess Coalition is pleased to announce its 2026 Board of Directors, now representing 16 member companies. In 2025, the Coalition welcomed new representatives from Google and NVIDIA, further strengthening its leadership and commitment to advancing open standards in the semiconductor industry.

Boot Barn Holdings, Inc. (NYSE: BOOT) (the “Company,” “we,” “us,” and “our”) today announced preliminary results for the third quarter of fiscal year 2026 ended December 27, 2025 in advance of its participation in the ICR Conference on Monday, January 12, 2026. A Supplemental Financial Presentation is available at investor.bootbarn.com.

Rosen Law Firm, a global investor rights law firm, reminds investors a class action on behalf of purchasers of securities and sellers of put options of Sprouts Farmers Market, Inc. (NASDAQ: SFM) between June 4, 2025 and October 29, 2025. Sprouts describes itself as a “specialty grocery store chain that operates throughout the US, with more than 450 stores across 24 states.”

DWS Municipal Income Trust (KTF) (the “Fund”) announced today its regular January monthly distribution.

Wynn Resorts announced today that Craig Jeffrey Fullalove will succeed Julie Cameron-Doe as Chief Financial Officer of Wynn Resorts, Limited. Ms. Cameron-Doe has elected to retire in mid-2026 but will continue to serve as a consultant to the Company and as a Non-Executive Director of Wynn Macau, Limited. Mr. Fullalove is currently the Chief Financial Officer and Chief Administrative Officer of Wynn Resorts’ Macau operations, and its Hong Kong-listed entity, Wynn Macau, Limited.

Mettler-Toledo International Inc. (NYSE: MTD) announced it will release its fourth quarter 2025 financial results after the market close on Thursday, February 5, 2026. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company’s website, investor.mt.com.

Royal Gold, Inc. (NASDAQ: RGLD) (together with its subsidiaries, “Royal Gold” or the “Company”) announced today that management will present at the 29th Annual CIBC Western Institutional Investor Conference.

The Board of Directors of Duff & Phelps Utility and Infrastructure Fund Inc. (NYSE: DPG), a closed-end fund advised by Duff & Phelps Investment Management Co., previously announced the following monthly distribution on September 18, 2025:

Healthpeak Properties, Inc. (NYSE: DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, is scheduled to report fourth quarter 2025 financial results after the close of trading on the New York Stock Exchange on Monday, February 2, 2026.

The Board of Directors of DNP Select Income Fund Inc. (NYSE: DNP), a closed-end fund advised by Duff & Phelps Investment Management Co. (the “Adviser”), previously announced the following monthly distribution on September 18, 2025: